12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Delphi Genetics, Merck deal

Delphi granted Merck a non-exclusive license to use StabyExpress technology for protein expression in research and product development. Delphi...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >